Tremendous uncertainty awaits, though I expect that we will see a slowing down of the repeal and replace process, with even the individual mandate persisting for some time; unmaking the Affordable Care Act without leaving millions stranded will be harder than the campaign may have suggested.
January 5, 2017
We believe the bill’s potential benefits and modestly enhanced funding for scientific advancement are far outweighed by the increased risk of patient harm, and added pressure on the FDA to rush new products to market without adequate evidence.
November 30, 2016
As physicians, I think we can all agree that we desperately need to restore and maximize human touch in medicine. When technology helps us achieve that, we should embrace it.
November 15, 2016
Extra monopolies have caused US consumers to pay higher prices for medicines for longer periods of time while making the pharmaceutical industry far more profitable than any other industry. The next president and Congress should take several key steps to roll back costly, unnecessary monopolies.
September 13, 2016
There are few examples where Democrats and Republicans in Congress, as well as those among the public who identify with the two parties, agree on a set of policies. One of these exceptions involves policies to address the opioid abuse crisis facing the country today.
September 12, 2016
CARA's ability to fill the so called treatment gap is severely limited by the minimal level of funding to expand evidence-based treatment. Without appropriations, it is a powerful statement but not necessarily an actionable plan.
September 12, 2016
A New Jersey foundation believes that a more comprehensive approach to pain care and the prescription opioid addiction crisis represents a key opportunity to have a long-term impact on the primary care system.
September 8, 2016
If Mylan can be faulted, it is on misjudging what ethical customs American society wishes to impose on for-profit business firms serving the health care industry. The current uproar over the company’s pricing policies, along with earlier outrages over Turing’s and Valeant’s pricing policies,...
September 6, 2016
The opioid painkiller epidemic in Colorado was the focus of a session at this year's Colorado Health Symposium. The Colorado Health Foundation hosts this well-known annual forum.
August 25, 2016
The Right Place, Right Time research initiative interviewed vulnerable patients to learn their most urgent concerns about the health care system. They reported widespread distrust of the health care system and felt that they were seen as “less than” by health care professionals.
August 11, 2016